Patent 7241762 was granted and assigned to Pharmacia & Upjohn on July, 2007 by the United States Patent and Trademark Office.
Disclosed herein are methods of treating an individual suffering from peripheral neuropathy. The methods generally include administration of a therapeutic amount of racemic reboxetine, or a pharmaceutically acceptable salt thereof, to the individual.